Phacilitate Leaders Forum

17th - 18th SEPTEMBER 2019

ROYAL LANCASTER LONDON

Speakers

Loading
Alberto Santagostino

Alberto Santagostino

SVP of Head of Cell and Gene Technologies, Lonza

Alberto is Head of the Cell and Gene Technologies Business Unit at Lonza Pharma & Biotech, the leading global CDMO with a prominent presence in new modalities. Together with his team, Alberto’s objective is to serve customers by taking their products through the technical CMC journey to commercialization and industrial scale manufacturing.

 

Before joining Lonza Pharma & Biotech, Alberto was a Partner at McKinsey & Company, accruing 12 years of experience working closely with established industry leaders and emerging players. Alberto led the Biotechnology service line, as well as the Pharmaceutical and Medical Product practice, and has a deep knowledge of the manufacturing challenges faced by companies in the biopharma space.

 

Alberto is passionate about biotechnology - the science and the business.

Sessions
Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
    Celyad
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd